Orphanin-fq/nociceptin: Lack of antinociceptive, hyperalgesic or allodynic effects in acute thermal or mechanical tests following intracerebroventricular or intrathecal administration to mice or rats

European Journal of Pain

Volumn 2, Issue 3, 1998, Pages 267-278

  Vanderah, Todd W ^a   Raffa, Robert B ^b   Lashbrook, Jason ^a   Burritt, Andrew ^c   Hruby, Victor ^c   Porreca, Frank ^a,d  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b University of Arizona   (United States)

^c TEMPLE UNIVERSITY   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; NALOXONE; NOCICEPTIN; OPIATE RECEPTOR;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; HOT PLATE TEST; HYPERALGESIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; MECHANICAL STIMULATION; MOUSE; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; TAIL FLICK TEST; THERMAL STIMULATION;

EID: 0031685394     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-3801(98)90023-4     Document Type: Article

References (85)

1. Andoh T, Itoh M, Kuraishi Y. Nociceptin gene expression in rat dorsal root ganglia induced by peripheral inflammation. NeuroReport 1997; 8: 2793-2796.
2. Bunzow JR, Saez C, Mortrud M, Bouvier C, Williams JT, Low M, Grandy DK. Molecular cloning and tissue distribution of a putative membrane of the rat opioid receptor gene family that is not μ, δ or κ opioid receptor type. FEBS Lett 1994; 347: 284-288.
3. 1J-nociceptin, a novel nociceptin analog, decreases systemic arterial pressure by a naloxone-insensitive mechanism in the rat. Biochem Biophys Res Comm 1997a; 234: 309-312.
4. Champion HC, Kadowitz PJ. Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the rat. Life Sci 1997b; 60: PL241-245.
5. Champion HC, Zadina JE, Kastin AJ, Hackler L, Ge LJ, Kadowitz PJ. The endogenous μ-opioid receptor agonists endomorphins 1 and 2 have novel hypotensive activity in the rabbit. Biochem Biophys Res Comm 1997; 235: 567-570.
6. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Meth 1994; 53: 55-63.
7. Chen Y, Fan Y, Liu J, Mestek A, Tian M, Cozak CA, Yu L. Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid gene family. FEBS Lett 1994; 347: 279-283.
8. 2+ in the SH-SY5Y human neuroblastoma cell line. Br J Pharmacol 1996a; 118: 205-207.
9. Connor M, Vaughan CW, Chieng B, Christie MJ. Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. Br J Pharmacol 1996b; 119: 1614-1618.
10. Dawson-Basoa M, Gintzler AR. Nociceptin (Orphanin FQ) abolishes gestational and ovarian sex steroid-induced antinociception and induces hyperalgesia. Br Res 1997; 750: 48-52.
11. Devine DP, Taylor L, Reinscheid RK, Monsma FJ Jr, Civelli O, Akil H. Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem Res 1996; 21: 1387-1396.
12. Dun NJ, Dun SL, Hwang LL. Nociceptin-like immunoreactivity in autonomic nuclei of the rat spinal cord. Neurosci Letts 1997; 234: 95-98.
13. Erb K, Liebel JT, Tegeder I, Zeilhofer HU, Brune K, Geisslinger G. Spinally delivered nociceptin/orphanin FQ reduces flinching behaviour in the rat formalin test. NeuroReport 1997; 8: 1967-1970.
14. Faber ES, Chambers JP, Evans RH, Henderson G. Depression of glutaminergic transmission by nociceptin in the neonatal rat hemisected spinal cord preparation in vitro. Br J Pharmacol 1996; 119: 189-190.
15. Florin S, Suaudeau C, Meunier JC, Costentin J. Nociceptin stimulates locomotion and exploratory behaviour in mice. Eur J Pharmacol 1996; 317: 9-13.
16. Fukuda K, Kato S, Mori K, Nishi M, Takeshima H, Iwabe N, Miyata T, Houtani T, Sugimoto T. cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett 1994; 343: 42-46.
17. Gintzler AR, Adapa ID, Toll L, Medina VM, Wang L. Modulation of enkephalin release by nociceptin (orphanin FQ). Eur J Pharmacol 1997; 325: 29-34.
18. Giuliani S, Maggi CA. Inhibition of tachykinin release from peripheral endings of sensory nerves by nociceptin, a novel opioid peptide. Br J Pharmacol 1996; 118: 1567-1569.
19. Grisel JE, Mogil JS, Belknap JK, Grandy DK. Orphanin FQ acts as a supraspinal, but not spinal, anti-opioid peptide. NeuroReport 1996; 7: 2125-2129.
20. Hao JX, Wiesenfeld-Hallin Z, Xu XJ. Lack of cross-tolerance between the antinociceptive effect of intrathecal orphanin FQ and morphine in the rat. Neurosci Letts 1997; 223: 49-52.
21. Hara N, Minami T, Okuda-Ashitaka E, Sugimoto T, Sakai M, Onaka M. Mori H, Imanishi T, Shingu K, Ito S. Characterization of nociceptin hyperalgesia and allodynia in conscious mice. Br J Pharmacol 1997; 121; 401-408.
22. Harrison JK, Barber CM, Lynch KR. Molecular cloning of a novel rat G-protein-coupled receptor gene expressed prominently in lung, adrenal, and liver. FEBS Lett 1993; 318: 17-22.
23. Heinricher MM, McGaraughty S, Grandy DK. Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla. J Neurophysiol 1997; 78: 3351-3358.
24. Henderson G, McKnight AT. The orphan opioid receptor and its endogenous ligand - nociceptin/orphanin FQ. Trends Pharmacol Sci 1997; 18: 293-300.
25. Helyes Z, Nemeth J, Pinter E, Szolcsanyi J. Inhibition by nociceptin of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals. Br J Pharmacol 1997; 121: 613-615.
26. Houtani T, Nishi M, Takeshima H, Nukada T, Sugimoto T. Structure and regional distribution of nociceptin/orphanin FQ precursor. Biochem Biophys Res Comm 1996; 219: 714-719.
27. Hylden JLK, Wilcox GW. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 1980; 67: 313-316.
28. Jenck F, Moreau JL, Martin JR, Kilpatrick GJ, Reinscheid RK, Monsma FJ Jr, Nothacker HP. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc Natl Acad Sci USA 1997; 94: 14854-14858.
29. Kavaliers M, Perrot-Sinal TS. Pronociceptive effects of the neuropeptide, nociceptin, in the land snail, Cepaea nemoralis. Peptides 1996; 17: 763-768.
30. King MA, Rossi GC, Chang AH, Williams L, Pasternak GW. Spinal analgesic activity of orphanin FQ/nociceptin and its fragments. Neurosci Letts 1997; 223: 113-116.
31. Knoflach F, Reinscheid RK, Civelli O, Kemp JA. Modulation of voltage-gated calcium channels by orphanin FQ in freshly dissociated hippocampal neurons. J Neurosci 1996; 16: 6657-6664.
32. Lachowicz JE, Shen Y, Monsma FJ Jr, Sibley DR. Molecular cloning of a novel g-protein-coupled receptor related to the opiate receptor family. J Neurochem 1995; 64: 34-40.
33. Lai CC, Wu SY, Dun SL, Dun NJ. Nociceptin-like immunoreactivity in the rat dorsal horn and inhibition of substantia gelatinosa neurons. Neurosci 1997; 81: 887-891.
34. Liebel JT, Swandulla D, Zeilhofer HU. Modulation of excitatory synaptic transmission by nociceptin in superficial dorsal horn neurones of the neonatal rat spinal cord. Br J Pharmacol 1997; 121: 425-432.
35. LoPachin RM, Rudy TA, Yaksh TL. An improved method for chronic catheterization of the rat spinal subarachnoid space. Physiol Behav 1981; 27: 559-561.
36. 2 on kappa receptor selectivity and potency. J Med Chem 1996; 39: 2456-2460.
37. Mansour A, Burke S, Reinscheid R, Nothacker H-P, Pavlic RJ, Akil H, Civelli O, Watson SJ. Orphanin FQ Peptide: an immunohistochemical and in situ hybridization study. TU16 abstract, INRC (1996) Long Beach, CA.
38. Matthes H, Seward EP, Kieffer B, North RA. Functional selectivity of orphanin FQ for its receptor coexpressed with potassium channel subunits in Xenopus laevis oocytes. Molec Pharmacol 1996; 50: 447-450.
39. Mattia A, Vanderah TW, Raffa RB, Vaught JL, Tallarida RJ, Porreca F. Characterization of the unusual antinociceptive profile of tramadol in mice. Drug Dev Res 1993; 28: 176-182.
40. Meng F, Taylor LP, Hoversten MT, Ueda Y, Ardati A, Reinscheid RK, Monsma FJ, Watson SJ, Civelli O, Akil H. Moving from the orphanin FQ receptor to an opioid receptor using four point mutations. J Biol Chem 1996; 271: 32016-32020.
41. 1 receptor. Nature 1995; 377: 532-535.
42. 2. Br J Pharmacol 1997; 122: 605-610.
43. Mogil JS, Grisel JE, Zhanges G, Belknap JK, Grandy DK. Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ. Neurosci Lett 1996a; 214: 131-134.
44. Mogil JS, Grisel JE, Reinscheid RK, Civelli O, Belknap JK, Grandy DK. Orphanin FQ is a functional anti-opioid peptide. Neurosci 1996b; 75: 333-337.
45. Mollereau C, Parmentier M, Mailleux P, Butour J-L, Moisand C, Chalon P, Caput D, Vassart G, Meunier J-C. ORL1, a novel member of the opioid receptor family: cloning, functional expression and localization. FEBS Lett 1994; 341: 33-38.
46. Mollereau C, Simons MJ, Soularue P, Liners F, Vassart G, Meunier J-C, Parmentier M. Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc Natl Acad Sci USA 1996; 93: 8666-8670.
47. Morgan MM, Grisel JE, Robbins CS, Grandy DK. Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ. NeuroReport 1997; 8: 3431-3434.
48. Murphy NP, Ly HT, Maidment NT. Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats. Neurosci 1996; 75: L4.
49. + evoked glutamate release from rat cerebrocortical slices. Br J Pharmacol 1996; 119: 1081-1083.
50. Nishi M, Takeshima H, Mori M, Nakagawara K, Takeuchi T. Structure and chromosomal mapping of genes for the mouse κ-opioid receptor and an opioid receptor homologue (MOR-C). Biochem Biophys Res Comm 1994; 205: 1353-1357.
51. Nishi M, Houtani T, Noda Y, Mamiya T, Sato K, Doi T, Kuno J, Takeshima H, Nukada T, Nabeshima T, Yamashita T, Noda T, Sugimoto T. Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphanin FQ receptor. EMBO J 1997; 16: 1858-1864.
52. Nothacker HP, Reinscheid RK, Mansour A, Henningsen RA, Ardati A, Monsma FJ Jr, Watson SJ, Civelli O. Primary structure and tissue distribution of the orphanin FQ precursor. Proc Natl Acad Sci (USA) 1996; 93: 8677-8682.
53. Ossipov, MH, Kovelowski, CJ, Nichols ML, Hruby VJ, Porreca F. Characterization of supraspinal antinociceptive actions of opioid δ agonists in the rat. Pain 1995; 62: 287-293.
54. Pan YX, Cheng J, Xu J, Rossi G, Jacobson E, Ryan-Moro J, Brooks AI, Dean GE, Standifer KM, Pasternak GW. Cloning and functional characterization through antisense mapping of a κ-3 related opioid receptor. Mol Pharmacol 1995; 47: 1180-1188.
55. Pasternak GW, Standifer KM. Mapping of opioid receptors using antisense oligodeoxynucleotides; correlating their molecular biology and pharmacology. Trends Pharmacol Sci 1995; 16: 344-350.
56. Patel HJ, Giembycz MA, Spicuzza L, Barnes PJ, Belvisi MG. Naloxone-insensitive inhibition of acetylcholine release from parasympathetic nerves innervating guineapig trachea by the novel opioid, nociceptin. Br J Pharmacol 1997; 120: 735-736.
57. Porreca F, Burks TF. The spinal cord as a site of opioid gastrointestinal effects in mice. J Pharmacol Exp Ther 1983; 227: 22-27.
58. Porreca F, Mosberg HI, Hurst R, Hruby VJ, Burks TF. Roles of μ, δ or κ opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J Pharmacol Exp Ther 1984; 230: 341-348.
59. Reinscheid RK, Nothacker H-P, Bourson A, Ardati A, Henningsen RA, Bunzow A, Grandy DK, Langen H, Monsma FJ Jr, Civelli O. Orphanin FQ: A neuropeptide that activates an opioidlike G protein-coupled receptor. Science 1995; 270: 792-794.
60. Riedl M, Shuster S, Vulchanova L, Wang J, Loh HH, Elde R. Orphanin FQ/nociceptin-immunoreactive nerve fibers parallel those containing endogenous opioids in rat spinal cord. NeuroReport 1996; 7: 1369-1372.
61. Rossi GC, Leventhal L, Pasternak GW. Naloxone sensitive orphanin FQ-induced analgesia in mice. Eur J Pharmacol 1996; 311: R7-R8.
62. Rossi GC, Leventhal L, Bolan E, Pasternak GW. Pharmacological characterization of orphanin FQ/nociceptin and its fragments. J Pharmacol Exp Ther 1997; 282: 858-865.
63. Saito Y, Maruyama K, Saido TC, Kawahima S. N23K, a gene transiently up-regulated during neural differentiation, encodes a precursor protein for a newly identified neuropeptide nociceptin. Biochem Biophys Res Comm 1995; 217: 539 545.
64. Saito Y, Maruyama K, Kawano H, Hagino-Yamagishi K, Kawamura K, Saido TC, Kawahima S. Molecular cloning and characterization of a novel form of neuropeptide gene as a developmentally regulated molecule. J Biol Chem 1996; 271: 15615-15622.
65. Schulz S, Schreff M, Nuss D, Gramsch C, Hollt V. Nociceptin/orphanin FQ and opioid peptides show overlapping distribution but not co-localization in painmodulatory brain regions. NeuroReport 1996; 7: 3021-3025.
66. Schuligoi R, Amann R, Angelberger P, Peskar BA. Determination of nociceptin-like immunoreactivity in the rat dorsal spinal cord. Neurosci Lett 1997; 224: 136-138.
67. 35S]GTPγS binding in rat brain. NeuroReport 1996; 7: 729-733.
68. Stanfa LC, Chapman V, Kerr N, Dickenson AH. Inhibitory action of nociceptin on spinal dorsal horn neurones of the rat, in vivo. Br J Pharmacol 1997; 120: 1875-1877.
69. Tian JH, Xu W, Fang Y, Mogil JS, Grandy DK, Han JS. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat. Br J Pharmacol 1997a; 120: 676-680.
70. Tian JH, Xu W, Zhang W, Fang Y, Grisel JE, Mogil JS, Grandy DK, Han JS. Involvement of endogenous orphanin FQ in electroacupuncture-induced analgesia. NeuroReport 1997b; 8: 497-500.
71. Vanderah TW. The direct and modulatory antinociceptive actions of endogenous and exogenous opioid delta agonists: The cloning of an orphan, opioid related gene. Ph.D. dissertation, University of Arizona, 1995.
72. Vanderah TW, Laughlin T, Lashbrook JM, Nichols ML, Wilcox GL, Ossipov MH, Malan TP Jr, Porreca F. Single injection of dynorphin A or des-tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone. Pain 1996; 68: 275-281.
73. 35S]γS binding sites in comparison with opioid agonist-stimulated ones in brain regions of mice. Neurosci Letts 1997; 237: 113-116.
74. Ueda H, Yamaguchi T, Tokuyama S, Inoue M, Nishi M, Takeshima H. Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene. Neurosci Letts 1997; 237: 136-138.
75. Vaughan CW, Christie MJ. Increase by the ORL1 receptor (opioid receptor-like 1) ligand, nociceptin of inwardly rectifying K conductance in dorsal raphe nucleus neurones. Br J Pharmacol 1996; 117: 1609-1611.
76. Vaughan CW, Ingram SL, Christie MJ. Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J Neurosci 1997; 17: 996-1003.
77. Wang JB, Johnson PS, Ima Y, Persico AM, Ozenberger BA, Eppler CM, Uhl GR. cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett 1994; 348: 75-79.
78. Wick MJ, Minnerath SR, Lin X, Eide R, Law P-Y, Loh HH. Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned μ, δ or κ opioid receptors. Mol Brain Res 1994; 27: 37-44.
79. Xu X-J, Hao JX, Wiesenfeld-Hallin Z. Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. NeuroReport 1996; 7: 2092-2094.
80. Yaksh TL, Rudy, TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976; 17: 1031-1036.
81. Yamamoto T, Nozaki-Taguchi N, Kimura S. Effects of intrathecally administered nociceptin, an opioid receptor-like 1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by carageenan injection into the rat paw. Brain Res 1997a; 754: 329-332.
82. Yamamoto T, Nozaki-Taguchi N, Kimura S. Effects of intrathecally administered nociceptin, an opioid receptor-like1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat. Neurosci Lett 1997b; 224:107-110.
83. Yamamoto T, Nozaki-Taguchi N, Kimura S. Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like 1 receptor agonist, in the rat formalin test. Neurosci 1997c; 81: 249-254.
84. Zhang YZ, Mulder H, Chang J-K, Danielsenl N, Sundler F. Orphanin FQ/nociceptin and its mRNA in rat spinal cord. TU19 abstract, INRC (1996) Long Beach, CA.
85. Zhu CB, Cao XD, Xu SF, Wu GC. Orphanin FQ potentiates formalin-induced pain behavior and antagonizes morphine analgesia in rats. Neurosci Letts 1997; 235: 37-40.